rs28933385
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A missense mutation in codon 200 (E200K) of the PRNP was identified in this patient; CSF 14-3-3 protein was positive; sleep disturbance was the initial sign and the other symptoms gradually appeared, including memory loss, dizziness and ataxia.
|
20514992 |
2010 |
rs767181086
|
|
|
0.010 |
GeneticVariation |
BEFREE |
A missense mutation in codon 200 (E200K) of the PRNP was identified in this patient; CSF 14-3-3 protein was positive; sleep disturbance was the initial sign and the other symptoms gradually appeared, including memory loss, dizziness and ataxia.
|
20514992 |
2010 |
rs63749884
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We reported a patient with early-onset FAD and the PSEN2 p.Met239Ile mutation, presenting with severe executive dysfunction and myoclonic tremor, associated with memory loss.
|
22531416 |
2012 |
rs761592007
|
|
|
0.010 |
GeneticVariation |
BEFREE |
We reported a patient with early-onset FAD and the PSEN2 p.Met239Ile mutation, presenting with severe executive dysfunction and myoclonic tremor, associated with memory loss.
|
22531416 |
2012 |
rs6311
|
|
|
0.010 |
GeneticVariation |
BEFREE |
No significant association was found between the SNPs analysed and response to escitalopram in patients with MDD though a significant association was seen between the side effect of memory loss and rs6311.
|
26261165 |
2015 |
rs1217691063
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In summary, high tHcy per se, or MTHFR C677T TT in combination with the APOE-ε4 allele, might be associated primarily with executive dysfunctions rather than memory loss.
|
26774227 |
2016 |
rs6265
|
|
|
0.010 |
GeneticVariation |
BEFREE |
While allelic variation in BDNF Val66Met may influence Aβ+ related neurodegeneration and memory loss over the short term, this is not related to serum mBDNF.
|
28720165 |
2017 |
rs759834365
|
|
|
0.010 |
GeneticVariation |
BEFREE |
While allelic variation in BDNF Val66Met may influence Aβ+ related neurodegeneration and memory loss over the short term, this is not related to serum mBDNF.
|
28720165 |
2017 |
rs63750424
|
|
|
0.010 |
GeneticVariation |
BEFREE |
MAPT p.R406W carriers present clinically with progressive memory loss and neuropathologically with neuronal and glial tauopathy.
|
30546007 |
2018 |
rs7695558
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Cognitively normal minor allele carriers of rs7695558 who developed incident AD showed accelerated memory loss prior to disease onset.
|
29154276 |
2018 |